Elizabeth Thiele, director of the Pediatric Epilepsy Program at Massachusetts General Hospital, and principal investigator on the trial, said: "The results of our open-label study of Epidiolex in ...

controlled phase 3 clinical trials and an open label extension study. In the phase 3 studies, Epidiolex added to other antiepileptic therapies significantly reduced the frequency of seizures in ...